Substituted morpholine compounds for the treatment of central nervous system disorders
US7659394B2 · kind B2 · utility
3Cited by
23References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2005 |
| Grant date | Feb 9, 2010 |
| Priority date | — |
| Expiry date | Oct 14, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds of the formulae Iwherein R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.